Among the preventative healthcare solutions on show at CES was QardioCore, a wearable ECG monitor set to be launched later in 2017. Created by US-based digital health company Qardio, QardioCore will be marketed as the first wearable medical ECG monitor which allows users to proactively monitor their heart health without the need for wires or patches.

Packed with proprietary sensor technology, QardioCore records more than 20 million data points, streaming the user’s live medical-grade data to their smartphones. The device is worn as a chest strap and records continuous ECG, heart rate, heart rate variability, respiratory rate, temperature and activity data.
The data can be easily – and automatically – shared with, for example, medical professionals. Athletes can also take advantage of QardioCore to help them achieve peak performance and optimise their training.

QardioCore pairs with the free Qardio app for iOS and works with iPhone, iPad and iPod, as well as Apple Health. It works alongside other Qardio products too, including: QardioArm, a smart blood pressure monitor; QardioBase, wireless scales and body analyser; and QardioMD, a dashboard for doctors.
“The ability to view and analyse such important data remotely and in context, as it’s being generated, can substantially enhance the diagnostic yield,” says Rosario Iannella, CTO at Qardio.

“For elite athletes, cardiovascular health is the cornerstone of performance. QardioCore puts a wealth of actionable biometrics including medical-grade beat-by-beat heart tracking into an athlete’s hands, empowering them to be their best.”